As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny. Rep. Lloyd Doggett’s (D-Texas) bill, H.R. 1046, the Medicare Negotiation and Competitive Licensing Act, was introduced on February 7, 2019 and has 126 cosponsors in the House. This legislation would […]
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in their television ads and a forthcoming executive order concerning drug prices.
Senate should be reminded when considering drug plans for Medicare and Medicaid that competition always leads to lower drug costs.
As the American Medical Association’s (AMA) shrinking membership tilts further and further to the left, real questions need to be asked about the organization’s influence over the Medicare for All debate. After the AMA resisted Medicare in 1966, roughly 70 percent of doctors were registered members of the group. During the Clinton era, the AMA […]
Listening to the Democratic presidential debates these past two days has been alarming. Pandering to specific groups, the candidates are prepared to have the federal government cover the costs for a myriad of programs. The New York Times wrote, “The Democrats’ two nights of debates showed that liberalism is on the march in the party. […]
The Los Angeles Times’s June 24 editorial, “San Francisco’s E-cigarette Ban Isn’t Just Bad Policy, it’s Bad for Public Health” is right on target. Today, San Francisco’s Board of Supervisors is scheduled to vote on banning the sales of electronic tobacco products, or e-cigarettes, within the city until the Food and Drug Administration adopts regulations […]
On Wednesday, June 12, 2019, the House Ways and Means Committee held a hearing with the intent to give Republicans and Democrats the chance to discuss other proposals to expand universal health care. Generally universal coverage means government-run healthcare. This was the first time a House committee of jurisdiction had formally assembled to examine universal […]
It has been said that one should never let a serious crisis go to waste. It could just as easily be said, “if there is no crisis, make one up to try to compel action and raise money.” A perfect example of the latter is the campaign undertaken by The Guardian, a left-leaning daily British […]
The Senate Health, Education, Labor, and Pensions (HELP) Committee will hold a hearing tomorrow on its draft legislation, “The Lower Health Care Costs Act of 2019.” It is an effort to get something done where there is agreement between the Republicans and the Democrats. The legislation addresses several issues such as surprise billing, prescription drug […]
Today, the Trump administration released a final rule on Health Reimbursement Arrangements (HRAs).
